Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2026-05-17 @ 7:21 PM
Study NCT ID:
NCT06673693
Status:
RECRUITING
Last Update Posted:
2025-04-16
First Post:
2024-10-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tislelizumab Combined With SBRT for the Treatment of Head and Neck Squamous Cell Carcinoma
Sponsor:
Sun Yat-sen University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2024-FXY-179
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None